MedPath

Triplessin

Brand Name: Triplessin

Generic Name: Terlipressin (as acetate)

Active
Registration Number

DRP-15065

Dosage Form

Solution for Injection (I.V.)

Issuance Date

April 2, 2024

Expiry Date

April 2, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 mg/ 10 mL
PackagingUSP Type-I Clear Glass Ampoule with Red and Blue Ring and White Ring Snap Off x 10 mL (Box of 1 ampoule)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Vasopressin and Analogues
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Terlipressin (as acetate)Active
Monograph: terlipressin (as acetate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform